127 related articles for article (PubMed ID: 30285510)
1. Relationship between the
Chen J; Ge D; Xiong Y
Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
[No Abstract] [Full Text] [Related]
2. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
[TBL] [Abstract][Full Text] [Related]
3. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
4. NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population.
Li X; Zhang C; Qiao W; Zhou X; Sun M
Int J Clin Exp Med; 2015; 8(1):1420-3. PubMed ID: 25785149
[TBL] [Abstract][Full Text] [Related]
5. The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population.
Wang Y; Chen L; Pan L; Xue J; Yu H
Int J Clin Exp Med; 2015; 8(5):8153-7. PubMed ID: 26221384
[TBL] [Abstract][Full Text] [Related]
6. The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.
Yalcin B; Atakan N; Alli N
Clin Exp Dermatol; 2008 Aug; 33(5):629-33. PubMed ID: 18616724
[TBL] [Abstract][Full Text] [Related]
7. NF-κB1 -94del/del ATTG polymorphic variant maintains CLL at an early, mildest stage.
Urbanowicz I; Wołowiec D; Wysoczańska B; Łacina P; Jonkisz A; Nahaczewska W; Tukiendorf A; Bil-Lula I; Bogunia-Kubik K; Pawlak E
Adv Clin Exp Med; 2021 May; 30(5):499-506. PubMed ID: 33982453
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
9. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer.
Oltulu YM; Coskunpinar E; Ozkan G; Aynaci E; Yildiz P; Isbir T; Yaylim I
Biomed Res Int; 2014; 2014():530381. PubMed ID: 24707489
[TBL] [Abstract][Full Text] [Related]
10. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
11. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.
Bu H; Rosdahl I; Sun XF; Zhang H
J Cancer Res Clin Oncol; 2007 Nov; 133(11):859-66. PubMed ID: 17492467
[TBL] [Abstract][Full Text] [Related]
12. [Relation of MBL ExonI 54 and NFκB1-94ins/del ATTG Polymorphism with Fever during Neutropenia in Patients with Acute Leukaemia after Chemotherapy].
Xu WN; Jiang ZJ; Li YH; Xiao HW; Gao Y; Pang Y; Ouyang L; Liu ZH; Zhang LQ; Wang Y; Xiao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1258-64. PubMed ID: 26524019
[TBL] [Abstract][Full Text] [Related]
13. The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis.
Adamzik M; Schäfer S; Frey UH; Becker A; Kreuzer M; Winning S; Frede S; Steinmann J; Fandrey J; Zacharowski K; Siffert W; Peters J; Hartmann M
Anesthesiology; 2013 Jan; 118(1):123-33. PubMed ID: 23249930
[TBL] [Abstract][Full Text] [Related]
14. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
Luo YQ; Wang D; Gong T; Zhu J
Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002
[TBL] [Abstract][Full Text] [Related]
15. Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
Zahednasab H; Mesbah-Namin SA; Sahraian MA; Balood M; Doosti R
Neurosci Lett; 2013 Jun; 545():46-9. PubMed ID: 23618653
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor NF-κB1 functional promoter polymorphism and its expression conferring the risk of Type 2 diabetes-associated dyslipidemia.
Chatterjee T; De D; Chowdhury S; Bhattacharyya M
Mamm Genome; 2020 Aug; 31(7-8):252-262. PubMed ID: 32851488
[TBL] [Abstract][Full Text] [Related]
17. NF-
Yu J; Hua M; Zhao X; Wang R; Zhong C; Zhang C; Wang R; Li G; He N; Hou M; Ma D
J Immunol Res; 2018; 2018():8170436. PubMed ID: 30140708
[TBL] [Abstract][Full Text] [Related]
18. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
Liang M; Xu X; Gong Y; Tang Y; Lin L
Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
[TBL] [Abstract][Full Text] [Related]
19. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
[TBL] [Abstract][Full Text] [Related]
20. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
